Skip to content

Drug interactions

Berotralstat + Tenofovir alafenamide

Severity: Moderate

Berotralstat and Tenofovir alafenamide: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Berotralstat inhibits P-glycoprotein, and tenofovir alafenamide is a P-gp substrate whose absorption depends on this transporter. Coadministration may increase tenofovir alafenamide exposure, though the clinical impact is likely modest given its low systemic dose.

What this interaction means in plain words

Berotralstat and Tenofovir alafenamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Berotralstat belongs to Miscellaneous; Tenofovir alafenamide belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Inhibition of intestinal P-glycoprotein by berotralstat increases absorption of tenofovir alafenamide.

What to do

Monitor for tenofovir adverse effects, including renal function, during coadministration. Dose changes are generally not required unless toxicity emerges.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Berotralstat and Tenofovir alafenamide, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Berotralstat with Tenofovir alafenamide?

MediHelp rates the interaction as moderate. Berotralstat and Tenofovir alafenamide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Berotralstat inhibits P-glycoprotein, and tenofovir alafenamide is a P-gp substrate whose absorption depends on this transporter. Coadministration may increase tenofovir alafenamide exposure, though the clinical impact is likely modest given its low systemic dose.

How serious is the interaction between Berotralstat and Tenofovir alafenamide?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for tenofovir adverse effects, including renal function, during coadministration. Dose changes are generally not required unless toxicity emerges.

What other medicines interact with Tenofovir alafenamide?

MediHelp also lists interactions of Tenofovir alafenamide with, for example, Apalutamide, Danicopan, Ifosfamide. The full list is on the Tenofovir alafenamide page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in